Last updated: May 6, 2026

Mast Cell Tumors in Dogs: A Complete Cancer Guide

Mast cell tumors are the most common malignant skin tumors in dogs, accounting for approximately 16% to 21% of all canine skin tumors. They are both common and unpredictable — a mast cell tumor can be a low-grade growth that is cured with simple surgery, or it can be an aggressive cancer that spreads throughout the body. Understanding the nature of these tumors, how they are graded and staged, and what treatment options are available empowers you to make the best decisions for your dog.

This guide walks you through everything you need to know about mast cell tumors in dogs, from initial discovery to long-term management.

What Are Mast Cell Tumors?

Mast cells are a normal part of the immune system. They are found throughout the body, but are particularly concentrated in the skin, respiratory tract, and gastrointestinal tract. Mast cells play an important role in allergic responses and immune defense — they contain granules filled with histamine, heparin, and other chemicals that are released when the body encounters an allergen or pathogen.

A mast cell tumor (MCT) develops when mast cells grow and divide uncontrollably, forming a mass. The tumor cells retain the ability to release the chemicals stored in their granules, which can cause local and systemic effects including swelling, redness, ulceration, and in severe cases, gastrointestinal ulcers, bleeding, and anaphylactic-like reactions.

Mast cell tumors are most commonly found in the skin and subcutaneous tissue, but they can also develop in internal organs including the spleen, liver, intestines, and bone marrow. Cutaneous (skin) mast cell tumors account for the vast majority of cases and are the focus of this guide.

Causes and Risk Factors

The exact cause of mast cell tumors is not fully understood, but several factors are known to increase risk.

Breed Predisposition

Certain breeds have a significantly higher incidence of mast cell tumors. Boxers are the most commonly affected breed and may account for up to 50% of all MCT cases in some studies. Fortunately, Boxers also tend to develop lower-grade tumors with a better prognosis. Other predisposed breeds include Boston Terriers, Bull Terriers, Staffordshire Bull Terriers, Labrador Retrievers, Golden Retrievers, Weimaraners, Beagles, Pugs, and Shar-Peis. Shar-Peis deserve special mention because they tend to develop multiple mast cell tumors and may present at a younger age than other breeds.

Genetic Mutations

Research has identified specific genetic mutations associated with mast cell tumors. The most important is a mutation in the KIT gene (also known as c-kit), which produces a protein involved in cell growth and survival. Mutations in KIT cause uncontrolled cell proliferation. KIT mutations are found in approximately 15% to 40% of mast cell tumors and are more common in higher-grade tumors. The presence of a KIT mutation has implications for both prognosis and treatment, as targeted therapies are available for KIT-mutant tumors.

Age

Mast cell tumors can occur at any age but are most commonly diagnosed in middle-aged to older dogs, typically between seven and nine years of age. They are uncommon in dogs under three years old, though young dogs in predisposed breeds can develop them.

Chronic Inflammation

There is some evidence that areas of chronic skin inflammation may be more susceptible to mast cell tumor development, though a clear causal relationship has not been established.

What Do Mast Cell Tumors Look Like?

One of the most challenging aspects of mast cell tumors is that they have no single characteristic appearance. They are often called the “great imitators” because they can resemble many other types of skin growths. Common presentations include:

• A raised, firm lump on or just beneath the skin surface. It may be pink, red, or the same color as the surrounding skin.
• A soft, fluctuant mass that may change in size from day to day. The size fluctuation occurs because the tumor cells release histamine, causing local swelling and inflammation that waxes and wanes.
• A hairless or ulcerated area that may bleed or ooze.
• An insect bite-like lesion that seems to appear and disappear.
• A wart-like growth that is easily mistaken for a benign skin tag.

Mast cell tumors most commonly develop on the trunk, limbs, and perineal (genital) area. Tumors in the inguinal region, perineum, preputial area, and nail beds tend to behave more aggressively regardless of their histologic grade.

The critical takeaway is this: any new skin lump or bump on your dog should be evaluated by a veterinarian. The only way to determine whether a growth is a mast cell tumor is through diagnostic testing — you cannot tell by appearance alone.

Diagnosis and Grading

Diagnosing and grading a mast cell tumor involves several steps, each providing important information that guides treatment decisions.

Fine Needle Aspirate (FNA)

The first step is usually a fine needle aspirate. A needle is inserted into the mass, cells are collected, and they are examined under a microscope. Mast cells have a distinctive appearance — they contain dark purple granules that are easily identifiable. An FNA can confirm that a mass is a mast cell tumor, but it cannot reliably determine the grade.

Biopsy and Histopathology

After an FNA confirms MCT, the tumor is either biopsied (a small sample is taken) or completely excised (removed surgically). The tissue is sent to a pathology laboratory where it is examined microscopically and assigned a histologic grade.

Two grading systems are used:

Patnaik grading system (three-tier):

• Grade I (well-differentiated) — The tumor cells closely resemble normal mast cells. These tumors are well-defined, grow slowly, and rarely metastasize. Prognosis is excellent with complete surgical excision.
• Grade II (intermediately differentiated) — The most common grade and the most variable in behavior. These tumors may act like Grade I (benign behavior) or Grade III (aggressive behavior). Additional testing is often needed to predict behavior.
• Grade III (poorly differentiated) — The tumor cells are highly abnormal. These tumors are aggressive, grow rapidly, and have a high rate of metastasis. Prognosis is guarded to poor.

Kiupel grading system (two-tier):

• Low grade — Corresponds roughly to Patnaik Grade I and most Grade II tumors. Good prognosis.
• High grade — Corresponds to Patnaik Grade III and some aggressive Grade II tumors. Poor prognosis without aggressive treatment.

Staging

Once the tumor is graded, staging determines whether the cancer has spread beyond the primary site. Staging typically includes:

• Regional lymph node evaluation — The lymph nodes closest to the tumor are aspirated and examined for mast cells. Spread to regional lymph nodes is an important prognostic factor.
• Abdominal ultrasound — To evaluate the spleen and liver for metastasis. The spleen is a common site of MCT spread.
• Blood work including buffy coat evaluation — To check for circulating mast cells in the blood.
• Bone marrow aspirate — May be performed in high-grade tumors or when systemic spread is suspected.

Treatment Options

Treatment for mast cell tumors depends on the grade, stage, location, and the number of tumors present.

Surgery

Surgery is the primary treatment for most mast cell tumors and is often curative for low-grade tumors. The goal is to remove the tumor with wide surgical margins — typically two to three centimeters of apparently normal tissue surrounding the tumor on all sides and one tissue plane deep to the tumor. These wide margins are necessary because mast cell tumors often extend microscopically beyond their visible borders.

The excised tissue is examined by a pathologist to determine whether the margins are “clean” (no tumor cells at the edges). Clean margins indicate complete removal, while “dirty” or “narrow” margins suggest that tumor cells may remain and additional treatment may be needed.

For tumors in locations where wide margins are not achievable (such as on a limb or near the face), a less aggressive surgery followed by radiation therapy may be recommended.

Radiation Therapy

Radiation therapy is used in several scenarios: to treat incompletely excised tumors where additional surgery is not feasible, as a definitive treatment for tumors that cannot be surgically removed, or in combination with surgery for high-grade tumors. Radiation is highly effective for local control of mast cell tumors. Treatment typically involves multiple sessions (usually 15 to 20) administered over several weeks. Most dogs tolerate radiation therapy well, with side effects limited to the treated area (skin irritation similar to sunburn).

Chemotherapy

Chemotherapy is recommended for high-grade mast cell tumors, tumors that have spread to lymph nodes or internal organs, and tumors with poor prognostic indicators. Common chemotherapy protocols include vinblastine and prednisone, which is the most frequently used combination. Lomustine (CCNU) is an oral chemotherapy drug used as an alternative. Chemotherapy can extend survival times significantly for dogs with aggressive mast cell tumors.

Targeted Therapy (Tyrosine Kinase Inhibitors)

Toceranib (Palladia) and masitinib (Kinavet) are targeted therapy drugs specifically developed for canine mast cell tumors. These drugs block the activity of the KIT protein and other growth factor receptors, inhibiting tumor cell growth. They are most effective for tumors that carry a KIT mutation but can also benefit some tumors without the mutation. Targeted therapy can be used as a primary treatment for inoperable tumors, as an adjunct to surgery, or for recurrent or metastatic disease. Side effects are generally manageable and include gastrointestinal upset and decreased appetite.

Supportive Medications

Because mast cell tumors release histamine and other chemicals, supportive medications are an important part of treatment:

• H1 antihistamines (diphenhydramine) — Block histamine effects on the skin and mucous membranes.
• H2 blockers or proton pump inhibitors (famotidine, omeprazole) — Protect the stomach from histamine-induced acid production, reducing the risk of gastrointestinal ulcers.
• Prednisone — Has direct anti-tumor effects on mast cells and also reduces inflammation.

Prognosis

The prognosis for dogs with mast cell tumors varies widely based on the grade, stage, location, and completeness of treatment:

• Low-grade (Kiupel) / Grade I (Patnaik) tumors — Excellent prognosis with complete surgical excision. Cure rates exceed 90%, and most dogs live normal lifespans after surgery.
• Intermediate Grade II (Patnaik) tumors — Variable prognosis. Many behave like low-grade tumors and have good outcomes with surgery alone. Others are more aggressive. Additional testing (mitotic index, KIT staining, Ki67) helps predict behavior.
• High-grade (Kiupel) / Grade III (Patnaik) tumors — Guarded prognosis. Without treatment, survival times may be only a few months. With aggressive treatment (surgery, chemotherapy, and/or radiation), median survival times range from approximately six to twelve months, with some dogs living longer.

Dogs that develop multiple mast cell tumors over their lifetime (common in breeds like Boxers) do not necessarily have a worse overall prognosis than dogs with a single tumor — each tumor is evaluated and treated independently based on its own grade and characteristics. Unlike hemangiosarcoma, which is almost always aggressive, mast cell tumors span a wide spectrum of behavior.

Long-Term Monitoring

After treatment for a mast cell tumor, ongoing monitoring is essential because new tumors can develop and treated tumors can occasionally recur.

Regular skin checks. Examine your dog’s entire body monthly for new lumps or bumps. Run your hands over every part of their body, feeling for anything new or different. Any new growth should be evaluated with an FNA promptly rather than taking a “wait and see” approach.

Veterinary follow-ups. Your veterinarian or veterinary oncologist will recommend a follow-up schedule based on the tumor grade and treatment. This typically includes physical examinations and possibly lymph node aspirates or imaging at regular intervals.

Report changes promptly. If you notice a lump changing in size (particularly if it seems to swell and shrink), if a surgical site becomes red or swollen after it had healed, or if your dog shows systemic signs like vomiting, loss of appetite, or dark tarry stools, contact your veterinarian promptly.

Frequently Asked Questions About Mast Cell Tumors in Dogs

Can Mast Cell Tumors in Dogs Be Benign?

Mast cell tumors are technically classified as malignant neoplasms. However, low-grade mast cell tumors behave in a benign fashion — they grow slowly, rarely metastasize, and are usually cured with complete surgical excision. In practical terms, a completely removed low-grade mast cell tumor has an outcome similar to a benign growth. The distinction matters because even low-grade tumors can recur if not completely excised, and because the grade cannot be determined without histopathology.

Should I Have Every Lump on My Dog Tested?

Yes, it is highly recommended to have any new lump or bump evaluated by your veterinarian, and a fine needle aspirate performed when indicated. Because mast cell tumors can mimic many other types of growths, it is impossible to determine whether a lump is a mast cell tumor based on appearance alone. An FNA is quick, inexpensive, and minimally invasive, and it provides critical information. Early detection and treatment of mast cell tumors significantly improves outcomes.

Can Mast Cell Tumors Cause Stomach Ulcers?

Yes, mast cell tumors can cause gastrointestinal ulcers. The tumor cells release histamine, which stimulates excess stomach acid production. This can lead to gastric and duodenal ulcers, which may cause vomiting (sometimes with blood), dark tarry stools (indicating digested blood), loss of appetite, and abdominal pain. This is why H2 blockers or proton pump inhibitors are routinely prescribed for dogs with mast cell tumors, even before surgery.

Is It Safe to Touch or Handle a Mast Cell Tumor?

Handling, squeezing, or pressing on a mast cell tumor can cause it to “degranulate” — releasing histamine and other chemicals from the tumor cells. This can cause the tumor to suddenly swell, become red, and develop a hive-like reaction around it (called a Darier sign). While this is not dangerous to you (MCTs are not contagious to humans), it can be uncomfortable for your dog and may complicate assessment of the tumor. Avoid repeatedly touching, pressing, or manipulating any suspected or confirmed mast cell tumor.

Can Dogs Develop Mast Cell Tumors in Internal Organs?

Yes, although the vast majority of mast cell tumors develop in the skin, they can also arise in internal organs including the spleen, liver, intestines, and bone marrow. Internal (visceral) mast cell tumors are less common but tend to be more aggressive than cutaneous tumors. Splenic mast cell tumors may present similarly to other splenic masses and can be confused with conditions like hemangiosarcoma. Intestinal mast cell tumors may cause vomiting, diarrhea, and weight loss. Internal MCTs generally carry a poorer prognosis than cutaneous tumors.